325 related articles for article (PubMed ID: 22500712)
1. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.
Miao YC; Tian JZ; Shi J; Mao M
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712
[TBL] [Abstract][Full Text] [Related]
2. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
Rogers SL; Doody RS; Mohs RC; Friedhoff LT
Arch Intern Med; 1998 May; 158(9):1021-31. PubMed ID: 9588436
[TBL] [Abstract][Full Text] [Related]
3. [Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial].
Yu L; Lin SM; Zhou RQ; Tang WJ; Huang PX; Dong Y; Wang J; Yu ZH; Chen JL; Wei L; Xing SL; Cao HJ; Zhao HB
Zhong Xi Yi Jie He Xue Bao; 2012 Jul; 10(7):766-76. PubMed ID: 22805083
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial.
Zhang Y; Lin C; Zhang L; Cui Y; Gu Y; Guo J; Wu D; Li Q; Song W
PLoS One; 2015; 10(6):e0130353. PubMed ID: 26076022
[TBL] [Abstract][Full Text] [Related]
5. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
Lee W; Kim M
Medicine (Baltimore); 2024 Jun; 103(24):e38067. PubMed ID: 38875437
[TBL] [Abstract][Full Text] [Related]
8. The effects of donepezil in Alzheimer's disease - results from a multinational trial.
Burns A; Rossor M; Hecker J; Gauthier S; Petit H; Möller HJ; Rogers SL; Friedhoff LT
Dement Geriatr Cogn Disord; 1999; 10(3):237-44. PubMed ID: 10325453
[TBL] [Abstract][Full Text] [Related]
9. Donepezil for vascular cognitive impairment.
Malouf R; Birks J
Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
[TBL] [Abstract][Full Text] [Related]
10. Effect and Safety of Huannao Yicong Formula () in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blinded, Donepezil-Controlled Trial.
Yang Y; Liu JP; Fang JY; Wang HC; Wei Y; Cao Y; Liu JG; Liu LT; Li H
Chin J Integr Med; 2019 Aug; 25(8):574-581. PubMed ID: 30109588
[TBL] [Abstract][Full Text] [Related]
11. Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial.
Wei MQ; Tian JZ; Shi J; Ma FY; Miao YC; Wang YY
Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1240-6. PubMed ID: 23158942
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.
Rogers SL; Friedhoff LT
Dementia; 1996; 7(6):293-303. PubMed ID: 8915035
[TBL] [Abstract][Full Text] [Related]
13. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
Dichgans M; Markus HS; Salloway S; Verkkoniemi A; Moline M; Wang Q; Posner H; Chabriat HS
Lancet Neurol; 2008 Apr; 7(4):310-8. PubMed ID: 18296124
[TBL] [Abstract][Full Text] [Related]
14. A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
Wilcock G; Howe I; Coles H; Lilienfeld S; Truyen L; Zhu Y; Bullock R; Kershaw P;
Drugs Aging; 2003; 20(10):777-89. PubMed ID: 12875613
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.
Salloway S; Ferris S; Kluger A; Goldman R; Griesing T; Kumar D; Richardson S;
Neurology; 2004 Aug; 63(4):651-7. PubMed ID: 15326237
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
17. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W
Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790
[TBL] [Abstract][Full Text] [Related]
19. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
Gu C; Shen T; An H; Yuan C; Zhou J; Ye Q; Liu T; Wang X; Zhang T
Neurosci Lett; 2015 Oct; 606():13-7. PubMed ID: 26297124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]